PetMed Express, Inc. (PETS) |
2.42 -0.12 (-4.72%) 10-10 16:00 |
Open: | 2.53 |
High: | 2.5601 |
Low: | 2.42 |
Volume: | 100,989 |
Market Cap: | 50(M) |
PE Ratio: | 242 |
Exchange: | NASDAQ Global Select |
Industry: | Medical - Pharmaceuticals |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 3.06 |
Resistance 1: | 2.82 |
Pivot price: | 2.57 |
Support 1: | 2.42 |
Support 2: | 2.01 |
52w High: | 6.85 |
52w Low: | 2.42 |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; telephone contact center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds and PetMeds brands. PetMed Express, Inc. was incorporated in 1996 and is headquartered in Delray Beach, Florida.
EPS | 0.010 |
Book Value | 4.660 |
PEG Ratio | 0.00 |
Gross Profit | 3.309 |
Profit Margin (%) | 0.14 |
Operating Margin (%) | -0.85 |
Return on Assets (ttm) | 0.9 |
Return on Equity (ttm) | 0.4 |
Fri, 10 Oct 2025
Securities Fraud Investigation Into PetMed Express, Inc. (PETS) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - MarketScreener
Thu, 09 Oct 2025
PetMed Express (PETS) Faces Investor Scrutiny Amid Filing - GlobeNewswire
Wed, 08 Oct 2025
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Wed, 08 Oct 2025
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Stock Titan
Sat, 16 Aug 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS - PR Newswire
Mon, 04 Aug 2025
Silvercape investments buys Petmed Express Inc (PETS) shares worth $379k By Investing.com - Investing.com
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |